Coverage: LD-2 reports for 2025 onward, posted Jan 1, 2025 through Oct 25, 2026. Only the current version of each report is used.
39,302 report citations, newest first.
POWER & COMMUNICATION CONTRACTORS ASSOCIATION · lobbying firm or registrant: GOVERNMENT AFFAIRS SOLUTIONS, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Labor Issues/Antitrust/Workplace
$50,000
Paid to lobbying firm
CitesS. 852· this member:Cosponsored
…awley's pro-labor organizing legislation. Opposition to FLCA discharge petition in the House. Opposition to Protecting the Right to Organize (PRO) Act (H.R. 20/S. 852). Opposition to the Warehouse Worker Protection Act (S.2613/H.R.4896.) Support for Senate HELP Committee legislative labor reforms, in general. Support for the…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BIOTECHNOLOGY INNOVATION ORGANIZATION · lobbying firm or registrant: BIOTECHNOLOGY INNOVATION ORGANIZATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Copyright/Patent/Trademark
$2,560,000
Spent on own lobbying
CitesS. 527· this member:Cosponsored
…ating Thickets to Increase Competition (ETHIC) Act ---H.R.9142: Prohibiting Adversarial Patents Act of 2026 ---S.43/H.R.6485: Skinny Labels, Big Savings Act ---S.527: Prescription Pricing for the People Act ---S.1041: Affordable Prescriptions for Patients Act ---S.1095: Stop STALLING Act ---S.1096: Preserve Access to Afford…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BIOTECHNOLOGY INNOVATION ORGANIZATION · lobbying firm or registrant: BIOTECHNOLOGY INNOVATION ORGANIZATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Health Issues
$2,560,000
Spent on own lobbying
CitesS. 2903· this member:Cosponsored
…9: Priority for Pediatric Cures Act ---S.822: Scientific EXPERT Act ---Rare Disease Pilot Program Reimbursement and Coverage of Innovative Products ---H.R.5509/S.2903:SAFE STEP Act ---S.864/H.R.6423: HELP Copays Act ---Access to Innovative Treatments ---CMMI Authority ---Implementation of the Inflation Reduction Act (IRA) of…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BIOTECHNOLOGY INNOVATION ORGANIZATION · lobbying firm or registrant: BIOTECHNOLOGY INNOVATION ORGANIZATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Health Issues
$2,560,000
Spent on own lobbying
CitesS. 526· this member:Cosponsored
…ovation (MINI) Act ---H.R.5391/S.2764 Protecting Patient Access to Cancer and Complex Therapies Act ---H.R.9418: Access to Innovative Treatments Act of 2026 ---S.526: Pharmacy Benefit Manager Transparency Act ---S.1097: Interagency Patent Coordination and Improvement Act ---S.1954: Biosimilar Red Tape Elimination Act ---S.3…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BIOTECHNOLOGY INNOVATION ORGANIZATION · lobbying firm or registrant: BIOTECHNOLOGY INNOVATION ORGANIZATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Health Issues
$2,560,000
Spent on own lobbying
CitesS. 527· this member:Cosponsored
…nd Traceability Drug Patenting ---H.R.3269/S.2276: Eliminating Thickets to Increase Competition (ETHIC) Act ---S.43/H.R.6485: Skinny Labels, Big Savings Act ---S.527: Prescription Pricing for the People Act ---S.1041: Affordable Prescriptions for Patients Act ---S.1095: Stop STALLING Act ---S.1096: Preserve Access to Afford…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BIOTECHNOLOGY INNOVATION ORGANIZATION · lobbying firm or registrant: BIOTECHNOLOGY INNOVATION ORGANIZATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Health Issues
$2,560,000
Spent on own lobbying
CitesS. 864· this member:Cosponsored
…c Cures Act ---S.822: Scientific EXPERT Act ---Rare Disease Pilot Program Reimbursement and Coverage of Innovative Products ---H.R.5509/S.2903:SAFE STEP Act ---S.864/H.R.6423: HELP Copays Act ---Access to Innovative Treatments ---CMMI Authority ---Implementation of the Inflation Reduction Act (IRA) of 2022 ---Medicare Part…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BIOTECHNOLOGY INNOVATION ORGANIZATION · lobbying firm or registrant: BIOTECHNOLOGY INNOVATION ORGANIZATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Medicare/Medicaid
$2,560,000
Spent on own lobbying
CitesS. 526· this member:Cosponsored
…to Innovative Cures (EPIC) Act ---H.R.1672: Maintaining Investments and New Innovation (MINI) Act ---H.R.6166: Lowering Drug Costs for American Families Act ---S.526: Pharmacy Benefit Manager Transparency Act ---S.527: Prescription Pricing for the People Act ---S.1096: Preserve Access to Affordable Generics and Biosimilars…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BIOTECHNOLOGY INNOVATION ORGANIZATION · lobbying firm or registrant: BIOTECHNOLOGY INNOVATION ORGANIZATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Medicare/Medicaid
$2,560,000
Spent on own lobbying
CitesS. 527· this member:Cosponsored
…cturing ---Compounded Medicines ---Drug Shortages ---Supply Chain Integrity and Traceability Drug Patenting ---S.43/H.R.6485: Skinny Labels, Big Savings Act ---S.527: Prescription Pricing for the People Act ---S.1095: Stop STALLING Act ---S.1096: Preserve Access to Affordable Generics and Biosimilars Act ---S.1097: Interage…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BIOTECHNOLOGY INNOVATION ORGANIZATION · lobbying firm or registrant: BIOTECHNOLOGY INNOVATION ORGANIZATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Medicare/Medicaid
$2,560,000
Spent on own lobbying
CitesS. 864· this member:Cosponsored
…termeasures ---WHO Pandemic Preparedness Accord Reimbursement and Coverage of Innovative Products ---H.R.6166: Lowering Drug Costs for American Families Act ---S.864/H.R.6423: HELP Copays Act ---CMMI Authority ---Medicare Part B Physician-Administered Products ---National Coverage Determination ---Patient Cost-Sharing and S…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BIOTECHNOLOGY INNOVATION ORGANIZATION · lobbying firm or registrant: BIOTECHNOLOGY INNOVATION ORGANIZATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Taxation/Internal Revenue Code
$2,560,000
Spent on own lobbying
CitesH.R. 1· this member:Recorded votes on 44 roll calls
…Orphan Drug Issues ---H.R.1414: Cameron's Law ---H.R.10359: Priority for Pediatric Cures Act Pandemic Preparedness Research & Development Tax Credit Reforms ---H.R.1: One Big Beautiful Bill Act ---H.R.1414: Cameron's Law ---Expensing of R&D Expenditures Vaccines and Infectious Disease ---H.R.9672: Vaccine Injury Compensatio…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL TOUR ASSOCIATION · lobbying firm or registrant: ELEVATE GOVERNMENT AFFAIRS, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Real Estate/Land Use/Conservation
$10,000
Paid to lobbying firm
CitesS. 1547· this member:Cosponsored
…(P.L. 116-152), issues related to commercial use authorizations. The One Big Beautiful Bill Act (P.L. 119-21). Issues related to the America the Beautiful Act (S.1547), Issues related to the Great American Outdoors Act 250 (H.R.9250).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
LINCOLN NATIONAL CORPORATION · lobbying firm or registrant: LINCOLN NATIONAL CORPORATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Taxation/Internal Revenue Code
$240,000
Spent on own lobbying
CitesH.R. 1· this member:Recorded votes on 44 roll calls
HR 1 / PL 119-21 One Big Beautiful Bill Act. HR 2547/S 1335 Secure Family Futures Act. Issue: debt investment tax change from capital to ordinary. Public Law 117-16…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
MAJOR LEAGUE SOCCER PLAYERS ASSOCIATION · lobbying firm or registrant: ELEVATE GOVERNMENT AFFAIRS, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Labor Issues/Antitrust/Workplace
$10,000
Paid to lobbying firm
CitesS. 4668· this member:Recorded votes on 11 roll calls
…ights and Endorsements (SCORE) Act (H.R.4312). Issues related to the College Athletics Reform Act (H.R.6350). Issues related to the Protect College Sports Act (S. 4668; H.R. 9137).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ALLIANZ · lobbying firm or registrant: VENN STRATEGIES
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Taxation/Internal Revenue Code
$50,000
Paid to lobbying firm
CitesS. 1335· this member:Cosponsored
International tax issues, including retaliatory taxes and administrative guidance from the OECD regarding Pillar II. S.1335/H.R.2547, the Secure Family Futures Act of 2025.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ALLIANZ · lobbying firm or registrant: VENN STRATEGIES
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Insurance
$50,000
Paid to lobbying firm
CitesS. 1335· this member:Cosponsored
International tax issues, including retaliatory taxes and administrative guidance from the OECD regarding Pillar II. S.1335/H.R.2547, the Secure Family Futures Act of 2025.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL HOCKEY LEAGUE PLAYERS ASSOCIATION · lobbying firm or registrant: ELEVATE GOVERNMENT AFFAIRS, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Labor Issues/Antitrust/Workplace
$10,000
Paid to lobbying firm
CitesS. 4668· this member:Recorded votes on 11 roll calls
…ights and Endorsements (SCORE) Act (H.R.4312). Issues related to the College Athletics Reform Act (H.R.6350). Issues related to the Protect College Sports Act (S. 4668; H.R. 9137).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL FOOTBALL LEAGUE PLAYERS ASSOCIATION · lobbying firm or registrant: ELEVATE GOVERNMENT AFFAIRS, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Labor Issues/Antitrust/Workplace
$10,000
Paid to lobbying firm
CitesS. 4668· this member:Recorded votes on 11 roll calls
…ights and Endorsements (SCORE) Act (H.R.4312). Issues related to the College Athletics Reform Act (H.R.6350). Issues related to the Protect College Sports Act (S. 4668; H.R. 9137).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NATIONAL BASKETBALL PLAYERS ASSOCIATION · lobbying firm or registrant: ELEVATE GOVERNMENT AFFAIRS, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · amended · posted Oct 21, 2026 · issue area: Labor Issues/Antitrust/Workplace
$10,000
Paid to lobbying firm
CitesS. 4668· this member:Recorded votes on 11 roll calls
…ights and Endorsements (SCORE) Act (H.R.4312). Issues related to the College Athletics Reform Act (H.R.6350). Issues related to the Protect College Sports Act (S. 4668; H.R. 9137).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN PIPELINE CONTRACTORS ASSOCIATION · lobbying firm or registrant: GOVERNMENT AFFAIRS SOLUTIONS, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Labor Issues/Antitrust/Workplace
$80,000
Paid to lobbying firm
CitesS. 852· this member:Cosponsored
…awley's pro-labor organizing legislation. Opposition to FLCA discharge petition in the House. Opposition to Protecting the Right to Organize (PRO) Act (H.R. 20/S. 852). Opposition to the Warehouse Worker Protection Act (S.2613/H.R.4896.) Support for Senate HELP Committee legislative labor reforms, in general. Support for the…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BLOCKCHAIN ASSOCIATION · lobbying firm or registrant: GOLDSTEIN POLICY SOLUTIONS LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Banking
$50,000
Paid to lobbying firm
CitesH.R. 3633· this member:Recorded vote on 1 roll call
H.R.3633 (CLARITY Act), also Senate version, H.R.7732 (Promoting Innovation in Blockchain Development Act), and H.R.3533 (Blockchain Regulatory Certainty Act), H.R.148…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BLOCKCHAIN ASSOCIATION · lobbying firm or registrant: GOLDSTEIN POLICY SOLUTIONS LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Commodities (big ticket)
$50,000
Paid to lobbying firm
CitesH.R. 3633· this member:Recorded vote on 1 roll call
H.R.3633 (CLARITY Act), also Senate version, H.R.7732 (Promoting Innovation in Blockchain Development Act), and H.R.3533 (Blockchain Regulatory Certainty Act), H.R.148…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BLOCKCHAIN ASSOCIATION · lobbying firm or registrant: GOLDSTEIN POLICY SOLUTIONS LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 21, 2026 · issue area: Financial Institutions/Investments/Securities
$50,000
Paid to lobbying firm
CitesH.R. 3633· this member:Recorded vote on 1 roll call
H.R.3633 (CLARITY Act), also Senate version, H.R.7732 (Promoting Innovation in Blockchain Development Act), and H.R.3533 (Blockchain Regulatory Certainty Act), H.R.148…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
FEDERAL HALL POLICY ADVISORS, LLC ON BEHALF OF DEFI EDUCATION FUND · lobbying firm or registrant: GOLDSTEIN POLICY SOLUTIONS LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Financial Institutions/Investments/Securities
$30,000
Paid to lobbying firm
CitesH.R. 3633· this member:Recorded vote on 1 roll call
…t H.R. 3314, Stop Presidential Profi teering from Digital Assets Act H.R. 3533, Blockchain Regulatory Certainty Act H.R. 3573, Stop TRUMP in Crypto Act of 2025 H.R. 3633, Digital Asset Market Clarity Act of 2025 S. 1223, Prohibiting Foreign Adversary Interference in Cryptocurrency Markets Act S. 1273, Combatting Money Launderin…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
FEDERAL HALL POLICY ADVISORS, LLC ON BEHALF OF DEFI EDUCATION FUND · lobbying firm or registrant: GOLDSTEIN POLICY SOLUTIONS LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Financial Institutions/Investments/Securities
$30,000
Paid to lobbying firm
CitesS. 1582· this member:Recorded votes on 9 roll calls
…y Act of 2025 S. 1223, Prohibiting Foreign Adversary Interference in Cryptocurrency Markets Act S. 1273, Combatting Money Laundering in Cyber Crime Act of 2025 S. 1582, Guiding and Establishing National Innovation for U.S. Stablecoins (GENIUS) Act Draft market structure legislation in Senate
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AGILITY ROBOTICS, INC. · lobbying firm or registrant: AGILITY ROBOTICS, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Defense
$60,000
Spent on own lobbying
CitesS. 4784· this member:Recorded vote on 1 roll call
Advanced technology, robotics, artificial intelligence, automation, H.R. 7334, S. 4686, H.R. 8800, S. 4784, H.R. 9129
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
